Clinical Trial Update: A Safety and Efficacy Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korean Patients [Phase 4]

View source ↗

Summary

Phase 4 safety and efficacy study evaluating botulinum toxin type A (BOTOX) for urinary incontinence due to neurogenic detrusor overactivity or overactive bladd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• Botox (onabotulinumtoxinA) (onabotulinumtoxinA)

Snippet

Sponsor: Allergan | Conditions: Urinary Incontinence, Overactive Bladder | Phase 4 | Status: COMPLETED